Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000435538 | SCV000519336 | benign | not specified | 2016-01-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001514365 | SCV001722193 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001702375 | SCV001933368 | benign | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001702449 | SCV001933369 | benign | Van Maldergem syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000435538 | SCV004233353 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 52% of patients studied by a panel of primary immunodeficiencies. Number of patients: 49. Only high quality variants are reported. |
Clinical Genetics, |
RCV000435538 | SCV001925913 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000435538 | SCV001957879 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000435538 | SCV001970648 | benign | not specified | no assertion criteria provided | clinical testing |